How much funding can be received?

Receive strategic guidance from an international Steering Committee of investors, healthcare executives, and advisors in order to position your company for fundraising periods and accelerate technology commercialization.

grant_single_labels|projects

The Capital Access Advisory Program focuses on initiatives that accelerate technology commercialization and prepare health science companies for successful Series A financing. Eligible activities support strategic business growth, enhance fundraising capabilities, and culminate with presentations to investors.

Business strategic planning to increase return on investment for investors.
Development and execution of advanced fundraising strategies and financial modeling.
Initiatives aimed at closing investment rounds effectively.
Participation in mentorship and guidance sessions with an international steering committee.
Engagement in investor readiness programs including targeting and introductions.
Preparation and presentation at the OBIO Investment Summit.

grant_single|admissibleProjectsExample

$ 70,000

Start a new fitness studio offering specialized wellness programs

$ 90,000

Create an online platform for financial literacy among teenagers

$ 100,000

Develop a new healthcare app to monitor patient vitals in real time

$ 120,000

Create a sustainable fashion brand using eco-friendly materials

$ 150,000

Launch a cooperative grocery store focused on local and organic products

$ 60,000

Establish a new non-profit organization focused on mental health awareness campaigns

grant_single_labels|admissibility

Eligibility for participation in OBIO’s CAAP® program requires meeting specific criteria related to company profile and funding stage.

The company must be in the health sciences sector.
The company should be starting to raise Series A financing in the Q4 2023 to 2024 timeframe.

grant_eligibility_criteria|who_can_apply

Participants in the OBIO® Capital Access Advisory Program (CAAP®) are health science companies embarking on raising Series A financing and aiming for high-value investment opportunities.

grant_eligibility_criteria|eligible_expenses

The CAAP® program supports activities centered around strategic business growth and investment attraction in the health sciences sector. Eligible activities are designed to enhance company readiness and success in securing Series A financing and strategic partnerships.

Business strategic planning and optimizing return on investment for investors.
Advanced fundraising strategies and comprehensive financial modeling.
Closing an investment round to secure funding.

grant_eligibility_criteria|zone

This grant is likely available to companies based in Canada, given that it is funded by both the Government of Canada and mentions Canadian initiatives.

Companies located in Canada.

grant_single_labels|criteria

There are evaluation and selection criteria for the OBIO CAAP® grant program:

Demonstrated potential for technology commercialization and scalability
Evidence of business strategic planning and market feasibility
Ability to articulate advanced fundraising strategies and financial modeling
Clear plan for closing an investment round

grant_single_labels|register

Here are the steps to submit an application for the OBIO® Capital Access Advisory Program (CAAP®):

Step 1: Check Eligibility
- Ensure your company is a health science company looking to raise Series A financing in Q4 2023 to 2024.
Step 2: Program Application
- Visit the OBIO® official website to find the CAAP® application form or contact the provided emails for access.
- Fill in the application form with company details, business strategy, and fundraising plans.
Step 3: Submit Application
- Email the completed application form to the contacts provided (e.g., christinayeh@obio.ca or jacklee@obio.ca).
- Ensure submission before any specified deadline.
Step 4: Review and Confirmation
- Wait for confirmation of receipt from OBIO®.
- They may request additional information or documents as needed.

grant_single_labels|otherInfo

Here are additional relevant details for this program:

The OBIO Investment Summit provides an opportunity for direct interaction with global health sciences investors and strategic partners.
Since 2018, over $1.6 billion has been raised by companies participating in the Summit, highlighting a successful track record.
Over 200 companies have previously presented at the OBIO Investment Summit, offering a platform for visibility and networking.
The program offers access to a network of advisors specializing in technology commercialization, business development, and fundraising.
Strategic guidance is provided by an international Steering Committee comprising investors, healthcare executives, and business experts.